Covid19

Sanofi, GSK say dual-acting vaccine prevents COVID-19 from omicron in large trial

A dual-acting vaccine directed against two coronavirus strains reduced the number of symptomatic COVID-19 cases associated with the omicron …

Read more at www.biopharmadive.com

Show More

Related Articles

Back to top button